CCND1 and renal cell adenocarcinoma: Amplification of chr11q13.3 is also frequently found in breast cancer,35 head and neck squamous cell carcinoma,36 renal cell cancer,37 and lymph node metastasis.38 It is worthwhile to test PI3Kα inhibitors in these cancers with CCND1 amplification.